CROI 2014: Raltegravir Plus Boosted Darunavir Is Safe and Effective for First-line ART

HIV treatment guidelines have historically recommended combination antiretroviral therapy consisting of a pair of nucleoside/nucleotide reverse transcriptase inhibitors plus a third drug from a different class, such as a non-nucleoside reverse transcriptase inhibitor or protease inhibitor.

http://ift.tt/NWJQFJ